- Home
- ATHA vs SRM Comparison
ATHA vs SRM Comparison
Compare ATHA & SRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHA
- SRM
- Stock Information
- Founded
- ATHA 2011
- SRM 1979
- Country
- ATHA United States
- SRM United States
- Employees
- ATHA N/A
- SRM N/A
- Industry
- ATHA Medicinal Chemicals and Botanical Products
- SRM
- Sector
- ATHA Health Care
- SRM
- Exchange
- ATHA Nasdaq
- SRM Nasdaq
- Market Cap
- ATHA 10.6M
- SRM 9.0M
- IPO Year
- ATHA 2020
- SRM 2023
- Fundamental
- Price
- ATHA $0.31
- SRM $7.75
- Analyst Decision
- ATHA Buy
- SRM
- Analyst Count
- ATHA 4
- SRM 0
- Target Price
- ATHA $11.25
- SRM N/A
- AVG Volume (30 Days)
- ATHA 1.3M
- SRM 20.0M
- Earning Date
- ATHA 07-31-2025
- SRM 08-11-2025
- Dividend Yield
- ATHA N/A
- SRM N/A
- EPS Growth
- ATHA N/A
- SRM N/A
- EPS
- ATHA N/A
- SRM N/A
- Revenue
- ATHA N/A
- SRM $4,394,659.00
- Revenue This Year
- ATHA N/A
- SRM N/A
- Revenue Next Year
- ATHA N/A
- SRM N/A
- P/E Ratio
- ATHA N/A
- SRM N/A
- Revenue Growth
- ATHA N/A
- SRM N/A
- 52 Week Low
- ATHA $0.22
- SRM $0.26
- 52 Week High
- ATHA $3.67
- SRM $12.80
- Technical
- Relative Strength Index (RSI)
- ATHA 49.52
- SRM 65.73
- Support Level
- ATHA $0.29
- SRM $7.20
- Resistance Level
- ATHA $0.35
- SRM $12.80
- Average True Range (ATR)
- ATHA 0.03
- SRM 1.68
- MACD
- ATHA -0.00
- SRM 0.53
- Stochastic Oscillator
- ATHA 14.10
- SRM 59.80
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.
About SRM SRM Entertainment Inc.
SRM Entertainment Inc is a trusted toy and souvenir designer and developer, selling into theme parks and entertainment venues. It has developed, manufactured, and supplied the entertainment and amusement park industry with exclusive products that are often only available to consumers inside SRM's customer base venues such as Walt Disney Parks and Resorts, Universal Studios, SeaWorld, Six Flags, Great Wolf Lodge, Dollywood, and Merlin Entertainment. Its product category includes The Smurfs and Zoonicorns, Sammy Sloth, lilita Llama, kyle Koala, and Hanna Hedgehog.